New hope for kids with severe skin condition
NCT ID NCT05388916
Summary
This study observed 42 children and teenagers in China with moderate to severe plaque psoriasis who were prescribed the medication Cosentyx. It aimed to collect real-world safety information and see how well the drug worked to clear or nearly clear their skin over one year. The study did not change their normal treatment plan; it simply tracked their progress during routine doctor visits.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MODERATE TO SEVERE CHRONIC PLAQUE PSORIASIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Guangzhou, Guangdong, 510091, China
-
Novartis Investigative Site
Shijiazhuang, Hebei, 050000, China
-
Novartis Investigative Site
Zhengzhou, Henan, 450018, China
-
Novartis Investigative Site
Shenyang, Liaoning, 110004, China
-
Novartis Investigative Site
Xian, Shanxi, 710004, China
-
Novartis Investigative Site
Hangzhou, Zhejiang, 310009, China
-
Novartis Investigative Site
Beijing, 100069, China
Conditions
Explore the condition pages connected to this study.